Showing results (1491-1500 of 14,263) with videos related to

Sort By:
Pageof 1,427
Diabetes|August 24, 2018
The Ascending GLP-1 Road From Clinical Safety to Reduction of Cardiovascular ComplicationsDaniel J Drucker
Diabetes|August 24, 2018
Microvascular Dysfunction and Hyperglycemia: A Vicious Cycle With Widespread ConsequencesCoen D A Stehouwer
Diabetes|July 8, 2018
Regulation of Human Adipose Tissue Activation, Gallbladder Size, and Bile Acid Metabolism by a β3-Adrenergic Receptor AgonistAlison S Baskin, Joyce D Linderman, Robert J Brychta, et al.
Diabetes|December 1, 1985
Beta-endorphin modulation of the glucoregulatory effects of repeated epinephrine infusion in normal dogsK M el-Tayeb, P L Brubaker, M Vranic, et al.
Diabetes|October 1, 1986
Decreased myo-inositol content and Na+-K+-ATPase activity in superior cervical ganglion of STZ-diabetic rat and prevention by aldose reductase inhibitionD A Greene, A M Mackway
Diabetes|November 1, 1986
Glutathione redox state is not the link between polyol pathway activity and myo-inositol-related Na+-K+-ATPase defect in experimental diabetic neuropathyP B Carroll, B M Thornton, D A Greene
Diabetes|August 18, 2018
Whole-Organism Chemical Screening Identifies Modulators of Pancreatic β-Cell FunctionHiroki Matsuda, Sri Teja Mullapudi, Yu Hsuan Carol Yang, et al.
Diabetes|June 1, 1986
Long-term plasma glucose normalization in experimental diabetic rats with macroencapsulated implants of benign human insulinomasJ J Altman, D Houlbert, P Callard, et al.
Diabetes|June 1, 1986
Coxsackie virus B4 produces transient diabetes in nonhuman primatesJ W Yoon, W T London, B L Curfman, et al.
Diabetes|March 17, 1999
The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particlesJ Janson, R H Ashley, D Harrison, et al.
Pageof 1,427